Incannex Healthcare (IXHL) Accumulated Expenses (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Accumulated Expenses of $1.6 million for Q1 2026, down 65.41% year-on-year from $4.7 million in Q1 2025, and up 29.94% on a QoQ basis from $1.3 million in Q4 2025.
Incannex Healthcare (IXHL) Accumulated Expenses (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Accumulated Expenses for 7 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- Quarterly Accumulated Expenses fell 65.41% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 65.41% YoY) and the FY2025 annual result came in at $6.1 million, up 25.99% from the prior year.
- Accumulated Expenses climbed to $1.6 million in Q1 2026 per IXHL's latest filing, from $1.3 million in the prior quarter.
- Over the last five years, Accumulated Expenses for IXHL reached as high as $7.5 million in Q3 2024 and fell as low as $415449.0 in Q2 2022.
- A 5-year average of $2.9 million and a median of $1.5 million in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Accumulated Expenses soared 603.19% — and 2025, when it tumbled 82.69%.
- Year by year, Accumulated Expenses stood at $415449.0 in 2022, then surged by 156.35% to $1.1 million in 2023, then surged by 222.54% to $3.4 million in 2024, then slumped by 63.44% to $1.3 million in 2025, then climbed by 29.94% to $1.6 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $1.6 million, $1.3 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 4.72 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 7.49 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Jun 30, 2023 | 689,000.00 |
| Jun 30, 2022 | 415,449.00 |
| Jun 30, 2021 | 381,717.00 |
| Jun 30, 2020 | 316,046.00 |